600200.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:00):

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China...

Stats
Today's Volume	39.50M
Average Volume	54.47M
Market Cap	7.71B
EPS	CNY0 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-364.67
ATR14	CNY0.0190 (0.17%)

Volume Correlation

Long: 0.11 (neutral)

Short: 0.10 (neutral)

Signal:(61.168) Neutral

JiangSu WuZhong Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

JiangSu WuZhong Correlation - Currency/Commodity

-0.27
( neutral )

-0.32
( neutral )

0.00
( neutral )

-0.22
( neutral )

0.52
( weak )

-0.05
( neutral )

JiangSu WuZhong Financials

Annual	2022
Revenue:	CNY2.03B
Gross Profit:	CNY579.66M (28.61 %)
EPS:	CNY-0.110

Q3	2023
Revenue:	CNY402.72M
Gross Profit:	CNY118.77M (29.49 %)
EPS:	CNY-0.0231

Q2	2023
Revenue:	CNY488.85M
Gross Profit:	CNY153.31M (31.36 %)
EPS:	CNY-0.00110

Q1	2023
Revenue:	CNY611.78M
Gross Profit:	CNY153.97M (25.17 %)
EPS:	CNY0.0395

Financial Reports:

No articles found.

JiangSu WuZhong

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.